Luis F. Mayorga
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Distinct microbial mediators link diet to inflammation in Crohn's disease and ulcerative colitis.
Journal: Gut
Published: November 04, 2025
Higher ustekinumab concentrations in induction are associated with better endoscopic outcomes in inflammatory bowel disease.
Journal: Therapeutic advances in gastroenterology
Published: April 11, 2025
Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology.
Journal: Biomarker research
Published: February 04, 2025
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU.
Journal: United European gastroenterology journal
Published: September 05, 2024
Antiphospholipid syndrome autoantibodies induction after treatment with anti-TNF alpha therapy in patients with IBD.
Journal: Gastroenterologia y hepatologia
Published: July 12, 2024
Severe and refractory gastrointestinal toxicity due to immune checkpoint inhibitors: clinical experience in a tertiary referral hospital.
Journal: Revista espanola de enfermedades digestivas
Published: May 12, 2023
Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota.
Journal: Inflammatory bowel diseases
Published: October 09, 2022
Intercontinental Gut Microbiome Variances in IBD.
Journal: International journal of molecular sciences
Published: August 29, 2022
Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach.
Journal: Computational and structural biotechnology journal
Published: August 01, 2021
Normalization of long-term quality of life in Crohn's disease patients receiving ustekinumab.
Journal: Revista espanola de enfermedades digestivas
Published: November 20, 2020
Last Updated: 09/26/2026